Pfizer (PFE) Land & Improvements (2009 - 2011)

Pfizer has disclosed Land & Improvements across 3 years of filings, most recently posting $747.0 million for Q4 2011.

• In Q4 2011, Land & Improvements fell 5.56% year-over-year to $747.0 million; the TTM figure through Dec 2011 stood at $747.0 million (down 5.56% YoY), while the FY2011 annual figure was $747.0 million, down 5.56% from the prior year.
• Land & Improvements fell to $747.0 million in Q4 2011, from $791.0 million in the prior quarter.
• Over the last five years, Land & Improvements for PFE reached as high as $937.0 million in Q4 2009 and fell as low as $747.0 million in Q4 2011.
• The 3-year median for Land & Improvements is $791.0 million (2010), against an average of $825.0 million.
• Annual changes were most pronounced in 2010 — Land & Improvements fell 15.58% — and 2011, when it dropped 5.56%.
• A 3-year view of Land & Improvements shows it stood at $937.0 million in 2009, then decreased by 15.58% to $791.0 million in 2010, then slipped by 5.56% to $747.0 million in 2011.
• According to Business Quant data, Land & Improvements over the past three periods registered $747.0 million, $791.0 million, and $937.0 million for Q4 2011, Q4 2010, and Q4 2009 respectively.